Health Condition 1: F980- Enuresis not due to a substance orknown physiological condition
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. History of bed-wetting atleast twice in a week or more for consecutive 3 months according to the DSM-V 2. The patient whose parents are willing for their child s participation in clinical trial by giving informed written consent/assent. 3. Patients with age group of 6 to12 years of either sex will be selected.
Exclusion criteria
Exclusion criteria: 1)Patients with any known case of: - ADHD - CNS disorders - Epilepsy - Spina Bifida 2)Endocrine/Metabolic disorders: - Diabetes Insipidus - Urinary tract infections 3)Any obstruction in lower urinary tract. 4)Patients with congenital anomalies of the genito-urinary tract 5) Patients below 6 years and above 12 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the clinical efficacy of mandukaparni syrup and bimbi syrup in the management of shayyamutra (nocturnal enuresis) among children aged 6 to 12 years given for 30 days.Timepoint: Treatment will be given for 30 days Follow up will be done on 7th, 15th, 30th, 45th days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To assess the improvement in frequency and severity of bedwetting episodes during the course of treatment in both groups. 2) To record and compare any adverse effects or safety concerns observed with Mandukaparni and Bimbi syrup.Timepoint: Treatment will be given for 30 days Follow up will be done on 7th, 15th, 30th, 45th days | — |
Countries
India
Contacts
MAMs Sumatibhai shah ayurved mahavidyalaya